Vitura Health Statistics
Total Valuation
Vitura Health has a market cap or net worth of AUD 37.78 million. The enterprise value is 41.56 million.
| Market Cap | 37.78M |
| Enterprise Value | 41.56M |
Important Dates
The next estimated earnings date is Thursday, February 19, 2026.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | Sep 5, 2025 |
Share Statistics
Vitura Health has 662.74 million shares outstanding. The number of shares has increased by 7.01% in one year.
| Current Share Class | 662.74M |
| Shares Outstanding | 662.74M |
| Shares Change (YoY) | +7.01% |
| Shares Change (QoQ) | +11.33% |
| Owned by Insiders (%) | 34.70% |
| Owned by Institutions (%) | 5.60% |
| Float | 228.32M |
Valuation Ratios
The trailing PE ratio is 10.46.
| PE Ratio | 10.46 |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 4.75 |
| P/FCF Ratio | 14.62 |
| P/OCF Ratio | 14.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.47, with an EV/FCF ratio of 16.08.
| EV / Earnings | 12.50 |
| EV / Sales | 0.34 |
| EV / EBITDA | 6.47 |
| EV / EBIT | 7.93 |
| EV / FCF | 16.08 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.37 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.86 |
| Debt / FCF | 4.63 |
| Interest Coverage | 4.86 |
Financial Efficiency
Return on equity (ROE) is 7.12% and return on invested capital (ROIC) is 6.56%.
| Return on Equity (ROE) | 7.12% |
| Return on Assets (ROA) | 4.46% |
| Return on Invested Capital (ROIC) | 6.56% |
| Return on Capital Employed (ROCE) | 9.25% |
| Weighted Average Cost of Capital (WACC) | -2.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.69 |
| Inventory Turnover | 16.43 |
Taxes
In the past 12 months, Vitura Health has paid 1.64 million in taxes.
| Income Tax | 1.64M |
| Effective Tax Rate | 34.93% |
Stock Price Statistics
The stock price has decreased by -24.00% in the last 52 weeks. The beta is -1.69, so Vitura Health's price volatility has been lower than the market average.
| Beta (5Y) | -1.69 |
| 52-Week Price Change | -24.00% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 39.62 |
| Average Volume (20 Days) | 212,277 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitura Health had revenue of AUD 124.04 million and earned 3.32 million in profits. Earnings per share was 0.01.
| Revenue | 124.04M |
| Gross Profit | 33.75M |
| Operating Income | 5.24M |
| Pretax Income | 4.71M |
| Net Income | 3.32M |
| EBITDA | 5.64M |
| EBIT | 5.24M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 7.58 million in cash and 11.97 million in debt, with a net cash position of -4.39 million or -0.01 per share.
| Cash & Cash Equivalents | 7.58M |
| Total Debt | 11.97M |
| Net Cash | -4.39M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 47.60M |
| Book Value Per Share | 0.07 |
| Working Capital | 6.88M |
Cash Flow
In the last 12 months, operating cash flow was 2.67 million and capital expenditures -83,512, giving a free cash flow of 2.58 million.
| Operating Cash Flow | 2.67M |
| Capital Expenditures | -83,512 |
| Free Cash Flow | 2.58M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 27.21%, with operating and profit margins of 4.23% and 2.68%.
| Gross Margin | 27.21% |
| Operating Margin | 4.23% |
| Pretax Margin | 3.79% |
| Profit Margin | 2.68% |
| EBITDA Margin | 4.55% |
| EBIT Margin | 4.23% |
| FCF Margin | 2.08% |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.01% |
| Shareholder Yield | -3.50% |
| Earnings Yield | 8.80% |
| FCF Yield | 6.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vitura Health has an Altman Z-Score of 3.35 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.35 |
| Piotroski F-Score | 5 |